 recombin granulocyte-macrophag colony-stimul factor autolog bone marrow transplant relaps non-hodgkin lymphoma blood bone marrow progenitor growth studi phase II eastern cooper oncolog group trial sixteen patient relaps non-hodgkin lymphoma underw autolog bone marrow transplant infus recombin human granulocyte-macrophag colony-stimul factor rhgm-csf treatment involved-field radiotherapi mg/kg/d IV day total bodi irradi cgi autolog bone marrow IV hour first infus IV rhgm-csf micrograms/kg/d hour infus rhgm-csf neutrophil count platelet count day marrow re-infus toxic mild fever chill hypertens alopecia rash diarrhea stomat myalgia synovi knee effus neutrophil recoveri median day rang day marrow infus compar group histor control count median time day rang day median time self-sustain platelet count day rang day compar histor group bacteremia central venou cathet exit site infect staphylococcu epidermidi local infect giardia stool median rang colony-form unit granulocyte-macrophag cfu-gm progenitor kg stem cell progenitor cfu-gm cfu-granulocyt erythroid monocyt megakaryocyt cfu-gemm burst-form unit-erythroid bfu-e bone marrow day marrow re-infus proport peripher blood count day transplant neutrophil patient median decreas hour rhgm-csf infus data rhgm-csf therapi enhanc neutrophil recoveri stem cell matur element enhanc rate marrow stem cell earli progenitor popul size